Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Moujalled DM, Brown FC, Chua CC, Dengler MA, Pomilio G, Anstee NS, Litalien V, Thompson E, Morley T, MacRaild S, Tiong IS, Morris R, Dun K, Zordan A, Shah J, Banquet S, Halilovic E, Morris E, Herold MJ, Lessene G, Adams JM, Huang DCS, Roberts AW, Blombery P, Wei AH.
Moujalled DM, et al. Among authors: dengler ma.
Blood. 2023 Feb 9;141(6):634-644. doi: 10.1182/blood.2022016090.
Blood. 2023.
PMID: 36219880
Free PMC article.